^
Association details:
| Biomarker: | HER-2 fusion |
|---|---|
| Cancer: | Non Small Cell Lung Cancer |
| Drug: | Gilotrif (afatinib) (EGFR inhibitor, HER2 inhibitor, HER4 inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Title:
Real-world large-scale study of ERBB2 gene fusions and its response to afatinib in Chinese non-small cell lung cancer (NSCLC): A multicenter study.
Excerpt:
Patients with advanced ERBB2 fusion NSCLC showed a good outcome of afatinib…
DOI:
10.1200/JCO.2019.37.15_suppl.e13002
